Table 1.
PJI UKAs (pts) | Population age (years) | Time UKA—PJI symptoms (days) | Infection type | Initial treatment | Survival rate with no reoperation for infection | Survival rate with no reoperation for any cause | Mean FU (years) | |
---|---|---|---|---|---|---|---|---|
Group A | ||||||||
Chalmers et al. [14] | 21 (21) | 66 (51–87) | 199.9 ± 321.0 | 14 (67%) acute postop | 16 (76%) DAIR |
76% (2 years FU) |
57% (5 years FU) |
3 (1–9) |
3 (14%) acute hematog | 4 (19%) 2SE | |||||||
4 (19%) chronic | 1 (5%) 1SE | |||||||
Hernandez et al. [19] | 15 (15) | 58 (41–82) | 287.1 ± 571.5 | 5 (33.3%) acute postop | 11 (73.3%) DAIR |
71% (5 years FU) |
49% (5 years FU) |
4 (2–6) |
5 (33.3%) acute hematog | 4 (26.7%) 2SE | |||||||
5 (33.3%) chronic | ||||||||
Labruyere et al. [20] | 9 (9) | 67 (36–83) | – | 9 (100%) chronic | 5 (55.6%) DAIR | 55.6% | 55.6% |
5 (3–8) |
4 (44.4%) 1SE | ||||||||
Group B | ||||||||
Burger et al. [22] | 1 (1) | – | – | – | 1SE | 100% | 100% | – |
Mohammad et al. [23] | 3 (3) | – | – | – | 1 (33%) Arthroscopic debridement and washout | 33% | 33% | – |
2 (66%) DAIR | ||||||||
Pandit et al. [24] | 6 (5) | – | – | – | 6 (100%) 2SE | 100% | 100% | – |
Price et al. [25] | 5 (5) | – | – | – | 5 (100%) 1SE | 100% | 100% | – |
Saxler et al. [26] | 1 (1) | – | – | – | 1 (100%) Synoviectomy and Gentamicin Chain | 100% | 100% | – |
Singer et al. [21] | 6 (6) | – | – | – | 6 (100%) 1SE | 100% | 100% | – |
Winnock de Grave et al. [27] | 4 (4) | – | – | – | 4 (100%) 2SE | 100% | 100% | – |
Xue et al. [28] | 2 (2) | – | – | – | 2 (100%) 2SE | 100% | 100% | – |
DAIR debridement and implant retention, FU follow-up, PJI periprosthetic joint infection, Preop preoperative, TKA total knee arthroplasty, 1SE one-stage revision procedures, 2SE two-stage revision procedures, (-) not reported